HESI LPN
HESI PN Exit Exam
1. Which condition is characterized by a progressive loss of muscle strength due to an autoimmune attack on acetylcholine receptors?
- A. Myasthenia gravis
- B. Multiple sclerosis
- C. Amyotrophic lateral sclerosis
- D. Guillain-Barré syndrome
Correct answer: A
Rationale: The correct answer is A: Myasthenia gravis. Myasthenia gravis is characterized by muscle weakness caused by autoimmune attack on acetylcholine receptors at the neuromuscular junction. This results in impaired communication between nerves and muscles. Choice B, Multiple sclerosis, is a condition where the immune system attacks the protective myelin sheath covering the nerves in the central nervous system, leading to communication issues between the brain and the rest of the body. Choice C, Amyotrophic lateral sclerosis, is a progressive neurodegenerative disease affecting motor neurons in the brain and spinal cord, not involving acetylcholine receptors. Choice D, Guillain-Barré syndrome, is an acute condition where the immune system attacks the peripheral nerves, causing muscle weakness and paralysis, but it does not target acetylcholine receptors.
2. A client with uterine cancer asks the nurse, 'Which is the most common type of cancer in women?' The nurse replies that it is breast cancer. Which type of cancer causes the most deaths in women?
- A. Breast cancer
- B. Lung cancer
- C. Brain cancer
- D. Colon and rectal cancer
Correct answer: B
Rationale: Lung cancer is the leading cause of cancer-related deaths in women, surpassing even breast cancer. While breast cancer is more common, it is often detected early enough for effective treatment. Lung cancer, on the other hand, tends to be diagnosed at later stages, leading to higher mortality rates. Brain cancer and colon and rectal cancer are not the leading causes of cancer-related deaths in women, making them incorrect choices.
3. Which of the following is NOT a second-line agent used for the treatment of Tuberculosis?
- A. Amikacin
- B. Moxifloxacin
- C. Rifabutin
- D. Cycloserine
Correct answer: C
Rationale: The correct answer is C, Rifabutin. Rifabutin is actually a first-line drug used in the treatment of tuberculosis. Choices A, B, and D (Amikacin, Moxifloxacin, and Cycloserine) are considered second-line agents for tuberculosis treatment. These drugs are used when the first-line medications are either ineffective or cannot be tolerated by the patient.
4. Which of the following is a primary intervention for a patient experiencing hypoglycemia?
- A. Administering insulin
- B. Providing a complex carbohydrate meal
- C. Giving 15 grams of a fast-acting carbohydrate, like glucose tablets
- D. Encouraging the patient to exercise
Correct answer: C
Rationale: Giving 15 grams of a fast-acting carbohydrate, such as glucose tablets, is the primary intervention for hypoglycemia. This rapid-acting carbohydrate helps quickly raise blood sugar levels, providing immediate relief to the patient. Administering insulin (Choice A) would further lower blood sugar levels, exacerbating the hypoglycemia. Providing a complex carbohydrate meal (Choice B) would not act quickly enough to address the immediate low blood sugar issue. Encouraging the patient to exercise (Choice D) is inappropriate during hypoglycemia as it can further deplete glucose levels.
5. Which of the following is MOST LIKELY to increase the risk of a medication error?
- A. Not using abbreviations for medications
- B. Errors in the calculation of medication dosages
- C. Barcoding medication orders
- D. Utilizing unit dose dispensers
Correct answer: B
Rationale: Errors in the calculation of medication dosages are a significant risk factor for medication errors. When dosage calculations are incorrect, it can lead to administering the wrong amount of medication, posing serious harm to the patient. Avoiding abbreviations for medications, barcoding medication orders, and utilizing unit dose dispensers are all strategies aimed at reducing medication errors by enhancing accuracy and safety. Therefore, choices A, C, and D are incorrect as they are practices that help decrease, rather than increase, the risk of medication errors.
Similar Questions
Access More Features
HESI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access
HESI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All HESI courses Coverage
- 30 days access